Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
03 2019
Historique:
received: 01 09 2018
revised: 06 12 2018
accepted: 06 12 2018
pubmed: 13 1 2019
medline: 22 7 2020
entrez: 13 1 2019
Statut: ppublish

Résumé

End-stage liver fibrosis frequently progresses to portal vein thrombosis, formation of oesophageal varices, hepatic encephalopathy, ascites, hepatocellular carcinoma and liver failure. Mesenchymal stem cells (MSCs), when transplanted in vivo, migrate into fibrogenic livers and then differentiate into hepatocyte-like cells or fuse with hepatocytes to protect liver function. Moreover, they can produce various growth factors and cytokines with anti-inflammatory effects to reverse the fibrotic state of the liver. In addition, only a small number of MSCs migrate to the injured tissue after cell transplantation; consequently, multiple studies have investigated effective strategies to improve the survival rate and activity of MSCs for the treatment of liver fibrosis. In this review, we intend to arrange and analyse the current evidence related to MSC transplantation in liver fibrosis, to summarize the detailed mechanisms of MSC transplantation for the reversal of liver fibrosis and to discuss new strategies for this treatment. Finally, and most importantly, we will identify the current problems with MSC-based therapies to repair liver fibrosis that must be addressed in order to develop safer and more effective routes for MSC transplantation. In this way, it will soon be possible to significantly improve the therapeutic effects of MSC transplantation for liver regeneration, as well as enhance the quality of life and prolong the survival time of patients with liver fibrosis.

Identifiants

pubmed: 30635966
doi: 10.1111/jcmm.14115
pmc: PMC6378173
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1657-1670

Informations de copyright

© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Références

World J Gastroenterol. 2016 Jul 14;22(26):6036-48
pubmed: 27468195
ACS Nano. 2018 Jul 24;12(7):6536-6544
pubmed: 29943967
Exp Ther Med. 2017 Dec;14(6):5956-5964
pubmed: 29285145
Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):193-204
pubmed: 29223366
Mol Cell Biochem. 2017 May;429(1-2):113-122
pubmed: 28181132
Hepatology. 2013 Sep;58(3):1133-42
pubmed: 23686813
J Transl Med. 2016 Feb 09;14:45
pubmed: 26861623
Stem Cells. 2016 Jan;34(1):135-47
pubmed: 26389810
Hepatology. 2001 Feb;33(2):464-70
pubmed: 11172350
PeerJ. 2018 Feb 12;6:e4336
pubmed: 29456886
Cell Physiol Biochem. 2018;48(5):2161-2171
pubmed: 30114694
Int J Oncol. 2011 Jul;39(1):137-43
pubmed: 21537835
J Biomater Sci Polym Ed. 2012;23(18):2259-72
pubmed: 22182291
Genet Mol Res. 2017 Mar 15;16(1):
pubmed: 28301671
J Gastroenterol Hepatol. 2015 Jun;30(6):1065-74
pubmed: 25639333
J Hepatol. 2015 Mar;62(3):634-41
pubmed: 25450712
J Transl Med. 2012 Apr 25;10:75
pubmed: 22533821
Int J Rheum Dis. 2017 Sep;20(9):1219-1226
pubmed: 28217916
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:85-92
pubmed: 23855301
BMB Rep. 2017 Feb;50(2):58-59
pubmed: 28115038
J Cell Mol Med. 2017 Nov;21(11):2963-2973
pubmed: 28544786
Hepatology. 2016 Dec;64(6):2185-2197
pubmed: 27339398
J Cell Biochem. 2018 Mar;119(3):2939-2950
pubmed: 29130552
Stem Cells Dev. 2015 Mar 15;24(6):791-801
pubmed: 25315017
Cell Biol Int. 2017 Jan;41(1):51-61
pubmed: 27805290
Transplant Proc. 2015 Mar;47(2):412-8
pubmed: 25769583
Sci Rep. 2016 Feb 15;6:21005
pubmed: 26876222
Eur J Gastroenterol Hepatol. 2017 Apr;29(4):481-487
pubmed: 28253211
J Cell Mol Med. 2019 Mar;23(3):1657-1670
pubmed: 30635966
Eur Rev Med Pharmacol Sci. 2016 Dec;20(23):4905-4912
pubmed: 27981544
Biochem Biophys Res Commun. 2018 Feb 26;497(1):264-271
pubmed: 29428718
Int J Physiol Pathophysiol Pharmacol. 2016 Sep 30;8(3):128-139
pubmed: 27785340
Stem Cells. 2014 Oct;32(10):2702-13
pubmed: 24989835
Stem Cells Int. 2018 Mar 4;2018:6079642
pubmed: 29686713
Rom J Morphol Embryol. 2015;56(3):1043-50
pubmed: 26662137
Sci Rep. 2015 Feb 27;5:8616
pubmed: 25722117
Liver Int. 2014 Jan;34(1):33-41
pubmed: 23782511
Iran Biomed J. 2016 Sep;20(4):207-16
pubmed: 27130910
Stem Cells Int. 2016;2016:4626073
pubmed: 27022400
Appl Immunohistochem Mol Morphol. 2017 Nov/Dec;25(10):736-745
pubmed: 27153445
BMC Gastroenterol. 2014 Nov 25;14:198
pubmed: 25425284
Tissue Cell. 2016 Oct;48(5):544-51
pubmed: 27481213
Cell Transplant. 2017 Dec;26(12):1868-1877
pubmed: 29390880
Stem Cells Transl Med. 2016 Oct;5(10):1416-1424
pubmed: 27280796
World J Gastroenterol. 2012 Mar 14;18(10):1048-58
pubmed: 22416179
Liver Int. 2016 Aug;36(8):1151-9
pubmed: 26353075
Int J Mol Med. 2014 Oct;34(4):1110-6
pubmed: 25069637
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Cytotherapy. 2013 Oct;15(10):1266-74
pubmed: 23993301
Stem Cells Int. 2016;2016:5720413
pubmed: 26839564
J Cell Mol Med. 2018 Oct;22(10):5165-5169
pubmed: 30019838
Stem Cells Int. 2015;2015:871972
pubmed: 26347063
Biochem Cell Biol. 2017 Dec;95(6):628-633
pubmed: 28746817
Growth Factors. 2017 Oct;35(4-5):144-160
pubmed: 29110545
Hepatology. 2013 Apr;57(4):1550-63
pubmed: 23150236
J Transl Med. 2013 Mar 26;11:78
pubmed: 23531302
PLoS One. 2016 Dec 19;11(12):e0168372
pubmed: 27992490
Stem Cell Rev Rep. 2012 Sep;8(3):972-81
pubmed: 21989829
Liver Int. 2013 Nov;33(10):1490-6
pubmed: 23763455
J Cell Mol Med. 2015 Mar;19(3):511-20
pubmed: 25534251
Pharmazie. 2011 Jan;66(1):37-43
pubmed: 21391433
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):786-803
pubmed: 24969793
Asian Pac J Trop Med. 2014 Apr;7(4):321-4
pubmed: 24507685
Cell Biol Int. 2013 Apr;37(4):340-7
pubmed: 23408711
J Surg Res. 2013 Oct;184(2):1161-73
pubmed: 23809154
J Transl Med. 2012 Jun 26;10:133
pubmed: 22735033
Stem Cells Dev. 2013 Mar 15;22(6):845-54
pubmed: 23002959
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1279-1283
pubmed: 28754450
J Hepatol. 2015 Apr;62(4):871-8
pubmed: 25463533
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Int J Clin Exp Pathol. 2015 Aug 01;8(8):8912-20
pubmed: 26464632
Sci Rep. 2015 Sep 15;5:14135
pubmed: 26370741
Transpl Int. 2018 Jan;31(1):102-115
pubmed: 28805262
Int J Mol Med. 2018 Jun;41(6):3175-3184
pubmed: 29512750
J Hepatol. 2013 Mar;58(3):593-608
pubmed: 23419824
J Gastroenterol Hepatol. 2014 Aug;29(8):1620-8
pubmed: 24942592
Int J Mol Sci. 2017 Aug 25;18(9):
pubmed: 28841158
Cytotechnology. 2017 Feb;69(1):19-29
pubmed: 27990569
Stem Cells Transl Med. 2017 Jan;6(1):272-284
pubmed: 28170193
J Clin Transl Hepatol. 2014 Dec;2(4):217-21
pubmed: 26356872
Exp Mol Med. 2014 Aug 22;46:e110
pubmed: 25145391
J Surg Res. 2014 Jan;186(1):408-16
pubmed: 24071025
Stem Cells Transl Med. 2016 Sep;5(9):1247-56
pubmed: 27365486
J Gastroenterol Hepatol. 2018 Apr;33(4):774-780
pubmed: 29293276
Stem Cell Res Ther. 2017 Jun 13;8(1):143
pubmed: 28610623
Arab J Gastroenterol. 2017 Jun;18(2):87-97
pubmed: 28625529
J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:112-20
pubmed: 22320928
Stem Cells Dev. 2014 Oct 15;23(20):2482-9
pubmed: 24835895
World J Gastroenterol. 2017 Dec 14;23(46):8152-8168
pubmed: 29290652
World J Gastroenterol. 2016 Feb 14;22(6):2092-103
pubmed: 26877613

Auteurs

Chenxia Hu (C)

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, School of Medicine, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, PR China.

Lingfei Zhao (L)

Kidney Disease Center, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, PR China.
Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, Zhejiang, PR China.
Institute of Nephrology, Zhejiang University, Hangzhou, Zhejiang, PR China.

Jinfeng Duan (J)

The Key Laboratory of Mental Disorder Management of Zhejiang Province, Department of Psychiatry, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, PR China.

Lanjuan Li (L)

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, School of Medicine, First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, PR China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH